A moderate amount of a peptide-enhanced cancer drug goes a long way in treating breast cancers that metastasize […]
Month: January 2022
At the time of writing (24 January 2022), unvaccinated NHS workers in England have only until 3 February […]
By adapting techniques from the domain of artificial intelligence, such as deep learning, cognitive scientists from Osnabrück will […]
It’s often too much for parents to absorb, especially when they’re sleep deprived and stressed. A smartphone app […]
A problem with the reference list in this article by Richard Powell and colleagues (BMJ 2022;376:e065574; doi:10.1136/bmj-2021-065574) led […]
Beckley Psytech leads a new project focused on addressing psychiatric and neurological conditions through the use of psychedelic medicines.
The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to […]
Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial aliu Mon, 01/24/2022 – 11:34
With omicron on the prowl, FDA extends inspection pause into February fkansteiner Mon, 01/24/2022 – 10:01
AbbVie’s Skyrizi nabs psoriatic arthritis nod, its second, shortly after Rinvoq fkansteiner Mon, 01/24/2022 – 09:03